Totally False Assumptions...that Russia trial..." deadline was moved back by 6 months" or that " it means there have been problems ALREADY getting things up and running in Russia"...no evidence of that.
September is NOT THE DEADLINE...it represents the end of a "Window"
IMO IPIX is likely at the end of Clinical Trials in Russia, based upon 20 sites and 4-6 participants at each site.
In fact, it appears from the public regulatory filings accessable to the public...that RUSSIAN Trails will finish first... and could spur on Russian approval before U.S, and with it, the possibility of Russian Pharma stepping up into the shoes of U.S BP. IMO, the separate regulartory approval in Russian was to have dual approvals...and dual paths to monitize Brilacidin...
Also the 21 day mark for Clinicaltrials.gov filing of the commencement of U.S Trials IMO should be forthcoming ... any day now (and likely overdue...but don't see any reprecussions for dragging out the filing and keeping it under wraps). Once filed, we will see how granular or stealth Leo will be. IMO Leo will continue give little opportunity for short/funds to spoil the party...and likely drop "D'Bomb" on them.
It will all be about the strength of the trial results...IMO many are watching!
News 
Market Data 
Discover 
AI
